Article Information
History
- June 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Cell Cycle and Cancer Biology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
- 2Cell Biology Department, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73114
- ↵3To whom correspondence should be addressed susannah-rankin{at}omrf.org